W. R. Grace (NYSE:GRA) is a chemicals business on a relatively undemanding forward valuation of 12x EV/EBITDA and 16x FCF on my estimates reflecting its recent proposed acquisition of a small chemicals business.

The company has received an offer at an 8% premium to its current price. That offer may undervalue the business, but has already been raised once.

Despite a likely return to normal operating performance in its core operations, the company trades at a discount to its pre-COVID valuation, suggesting further upside.

READ FULL ARTICLE HERE